# FDA Inspection 816165 - Schwabe North America, Inc. - February 01, 2013

Source: https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/1a59770d-03a2-4041-95e1-6185cb4e2147
Source feed: FDA_Inspections

> FDA Inspection 816165 for Schwabe North America, Inc. on February 01, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 816165
- Company Name: Schwabe North America, Inc.
- Inspection Date: 2013-02-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271627 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/2a20f4c9-bff6-4252-8981-26339d01753b)
- [FDA Inspection 1253920 - 2025-02-19](https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/18e41b69-6cf2-47e6-8f14-41f89fa53c0f)
- [FDA Inspection 1253920 - 2025-02-19](https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/9380f389-6150-48c3-933d-7ff259060e60)
- [FDA Inspection 1157191 - 2021-09-21](https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/299c3445-c345-449c-b307-2e0782dc9c6a)
- [FDA Inspection 1157191 - 2021-09-21](https://www.keypedia.com/records/fda_inspections/schwabe-north-america-inc/3bfe45a2-4992-4587-88b9-5e34178168a0)

Company: https://www.keypedia.com/companies/schwabe-north-america-inc/ac030767-09e8-4377-99ee-7360176e40ed

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c